|
.Honoring
Successful Innovations From the Chemical Enterprise
Because
the innovations of industry are essential to a healthy economy, the
American Chemical Society’s (ACS’s) Industry Member Programs has
instituted the Regional Industrial Innovation Awards Program. This
regional awards program recognizes individuals and teams for their
creative innovations that have resulted in a commercial product or
process. This awards program also highlights the outstanding
contributions that the profession of chemistry has given to society, as
well as the corporate leadership that encouraged the dissemination of
knowledge that is facilitated in these innovations.
Join us in
honoring the recipient(s) of the ACS’s 31st Northeast Regional Industrial
Innovation Award – Drs. Steven J. Brickner,
Michael R. Barbachyn, Douglas K.
Hutchinson, William C.
Pfefferle, and Mr. Peter R. Manninen.
Drs. Steven J.
Brickner (Pfizer Inc.), Michael R. Barbachyn (Pharmacia), Douglas K.
Hutchinson (Abbott Laboratory), and Mr. Peter R. Manninen (Pharmacia) are
being honored for the discovery of Zyvox, the first member of the
oxazolidinone class of antibacterial agents. Dr. William C. Pfefferle of
Precision Combustion, Inc. is being honored for the industrial advances
such as the RCL catalytic combustor for ground gas turbine engines and the
Microlith catalytic reaction system which form the basis of high heat mass
transfer catalytic reactors for fast-lightoff automotive catalytic
converters and fuel processor reactors.
The program will
include a symposium in which the honorees will present their work, an
awards ceremony in which the honorees will be formally recognized, and
special company exhibits to showcase the work being recognized. This is a
wonderful opportunity for you to hear about cutting edge-science and
celebrate the creative innovations in industry.
For additional information, please visit
www.chemistry.org/industry/regionalawards, or contact Ms. Vanessa
Johnson-Evans, Program Manager, American Chemical Society, Industry Member
Programs, 1155 Sixteenth Street, NW, Washington, DC. 20036, 202-872-4373,
1-800-227-5558, ext. 4373, or
cheminnovations@acs.org. We look forward to seeing you!
SYMPOSIUM
Date/Time/Location
TBD
AWARDS CEREMONY
Date/Time/Location
TBD
HONOREES:
 Steven
Brickner
received his B.S. degree in chemistry from Miami University in 1976, his
M.S. and Ph.D. degrees in organic chemistry from Cornell University in
1978 and 1981, respectively. He also completed postdoctoral research at
the National Institute of Health (NIH) in 1982. Dr. Brickner initiated
UpJohn’s oxaolidinone discovery program. Dr. Brickner is currently a
research advisor at Pfizer Inc. He is the recipient of several awards and
honors including the Fred Kagan Lead Finding Award, and the Distinguished
Alumni Lecturer, College of Arts and Science, Miami University. He is a
member of the Forum on Emerging Infections, Institute of Medicine, the
recipient of 21 U.S. patents, coauthor of over 26 technical papers, and
has presented 40 technical papers.
 Michael R.
Barbachyn
received his B.S. degree in chemistry from Calvin College (Grand Rapids,
MI) in 1979, his Ph.D. degree in organic chemistry from Wayne State
University (Detroit, MI), and his postdoctoral studies in 1985 from Yale
University. Dr. Barbachyn is currently an associate director at Pharmacia
Corp. (Kalamazoo, MI). His interest lies in synthesis of biologically
active compounds, especially novel antibacterial, antifungal and antiviral
agents; synthetic methodology, especially asymmetric transformations and
transition metal mediated processes. Dr. Barbachyn is the recipient of
several honors including the Upjohn Award and two Fred Kagan Lead Finding
Awards. He is the recipient of 30 U.S. patents, coauthor of over 30
scientific publications, and the presenter of 60 scientific papers.
 Douglas K.
Hutchinson
received his B.S. degree in chemistry from Rose-Hulman Institute of
Technology (Terre Haute, IN) in 1977, his M.S. degree in organic chemistry
form Ohio State University in 1980, and his Ph.D. degree in organic
chemistry from Purdue University in 1987. He is currently a research
investigator at Abbott Laboratories (Abbott Park, IL). His interest lies
in synthetic organic chemistry related to biological active compounds,
especially antibacterial and antiviral agents, oxazolidinone antibacterial
agents, peptidomimetics, and organometallic candidates. Dr. Hutchinson is
the co-recipient of the 1995 Fred Kagan Lead Finding Award for eperezolid
and linezoid becoming clinical development candidates. He is the coauthor
of 20 publications, the recipient of 12 U.S. patents, and has presented
several scientific papers.
 Peter R.
Manninen
received his B.S. degree in chemistry from Michigan State University in
1985 and has completed graduate level chemistry courses at Central
Michigan University and Western Michigan University while employed at
Michigan Molecular Institute and Pharmacia. Mr. Manninen is currently a
research scientist at Pharmacia. He is the recipient of the Fred Kagan
Lead Finding Award for the discovery of Zyvox and eperizolid and the
co-recipient of Unit 1510 Achievement Award in 1995. Mr. Manninen is the
recipient of one U.S. patent, coauthor of seven publications, the
presenter of over ten technical papers, and coauthor of 31 internal
published study reports.
 William C.
Pfefferle
received his B.S. in chemical engineering from Drexel University and his
Ph.D. in physical chemistry from the University of Pennsylvania. He is
known as the “father of catalytic combustion.” In the early 1970’s, he
invented the original catalytic combustor for gas turbine engines. In
1986 and at the age of 63, Dr. Pfefferle co-founded Precision Combustion
Inc. (PCI), which is dedicated to developing clean and efficient
technology for clean air. He continues to work full-time to develop
catalytic devices for clean and efficient energy. The success of the
company is due to Dr. Pfefferle’s forty years of research on catalytic
combustion and pollution control. Dr. Pfefferle is the recipient of 90
U.S. patents, author of numerous technical papers advancing the boundaries
of combustion engineering science, and has strengthened competitive
position of the U.S. gas turbine and U.S. automotive emissions
industries.
|
